4//SEC Filing
OCLASSEN GLENN A 4
Accession 0001181431-11-050006
CIK 0001178711other
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 5:34 PM ET
Size
6.1 KB
Accession
0001181431-11-050006
Insider Transaction Report
Form 4
OCLASSEN GLENN A
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2011-09-19$5.80/sh+10,000$58,000→ 310,800 total - Purchase
Common Stock
2011-09-19$5.80/sh+10,000$58,000→ 73,457 total(indirect: See Footnote)
Footnotes (1)
- [F1]Shares held directly by the Reporting Person's spouse.
Documents
Issuer
Transcept Pharmaceuticals Inc
CIK 0001178711
Entity typeother
Related Parties
1- filerCIK 0001210529
Filing Metadata
- Form type
- 4
- Filed
- Sep 19, 8:00 PM ET
- Accepted
- Sep 20, 5:34 PM ET
- Size
- 6.1 KB